Addiction News

Psilocybin-assisted therapy induced positive personality changes in adults with alcohol use disorder, which may help to improve long-term outcomes by limiting traits that encourage relapse such as impulsiveness, according to study results.

Congress recently extended Medicare telehealth flexibilities that waive a requirement for an in-person visit before a patient can receive mental health services via telehealth.

Preliminary evidence indicates that glucagon-like peptide-1 receptor agonists like Ozempic and similar weight-loss drugs may also help treat substance use disorders.

Results of a decadeslong study recently published in BMJ found that suicide risk increased on New Year’s Day in most countries, while the risk varied by country on Christmas.

LOS ANGELES — Treatment with cannabidiol in young people with tuberous sclerosis complex led to significant improvements in several cognitive, behavioral and executive domains, data from ongoing survey show.

Although key steps have been taken to improve access to naloxone for the acute treatment of opioid overdose, more work is needed to overcome the stigma associated with the root cause — substance use disorder.

New data show that rapid initiation with once-monthly Sublocade significantly improved treatment retention vs. standard initiation among patients with opioid use disorder, according to a press release.

Patients with alcohol use disorder who used GLP-1 agonists to treat obesity or type 2 diabetes had a decreased risk for hospitalization due to alcohol use disorder, according to a study published in JAMA Psychology.

Fentanyl-involved overdose mortality rates were disproportionately high among American Indian or Alaska Native and Black individuals compared with other racial and ethnic groups, according to a research letter published in JAMA Psychiatry.